Flubenvet 5 % w/w Premix for Medicated Feeding Stuff

Pays: Royaume-Uni

Langue: anglais

Source: VMD (Veterinary Medicines Directorate)

Ingrédients actifs:

Flubendazole

Disponible depuis:

Eli Lilly and Company Limited

Code ATC:

QP52AC12

DCI (Dénomination commune internationale):

Flubendazole

forme pharmaceutique:

Premix for medicated feeding stuff

Type d'ordonnance:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

Groupe thérapeutique:

Chickens, Geese, Partridge, Pheasants, Turkeys

Domaine thérapeutique:

Anthelmintic

Statut de autorisation:

Authorized

Date de l'autorisation:

2000-09-17

Résumé des caractéristiques du produit

Revised: June 2012
AN: 00170/2012
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Flubenvet 5 % w/w Premix for Medicated Feeding Stuff
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each gram contains:
ACTIVE SUBSTANCE:
Flubendazole
50 mg
EXCIPIENT:
Titanium dioxide
20 mg
For full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Premix for medicated feeding stuff
White to slightly yellow powder.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Pheasant, partridge, chicken, goose, and turkey.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Flubendazole is a broad spectrum anthelmintic, effective against
mature and
immature stages and eggs of the following nematodes of chickens,
turkeys,
geese, partridges and pheasants:
In the gastrointestinal tract:_Ascaridia galli, Heterakis gallinarum,
Capillaria _spp_., _
_Amidostomum anseris _and _Trichostrongylus tenuis._
In the respiratory tract:
_Syngamus trachea_
4.3
CONTRAINDICATIONS
None known
4.4
SPECIAL WARNINGS FOR TARGET SPECIES
None.
Revised: June 2012
AN: 00170/2012
4.5
SPECIAL PRECAUTIONS FOR USE
None.
i.
Special precautions for use in animals
None.
ii.
Special precautions to be taken by the person administering the
veterinary
medicinal product to animals
Accidental ingestion by humans should be avoided. May cause
sensitisation
by skin contact. May cause skin and eye irritation. Avoid direct skin
contact.
Wear overalls, safety glasses and impervious gloves when mixing and
handling the product. Wash affected parts if skin contact occurs. If
accidental
eye contact occurs, immediately rinse thoroughly with water. If the
operations involve potential exposure to dust, wear either a
disposable filter
and half-mask respirator conforming to European Standard EN149, or a
non-
disposable respirator to European Standard EN140 fitted with a filter
to
EN143.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
None known.
4.7
USE DURING PREGNANCY, LACTATION OR LAY
Not applicable.
4.8
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS